Gestão de Antimicrobianos
Comentário de estudo | Antibióticos para pneumonia pediátrica: menos pode ser suficiente?
18 Mai, 2022 | 16:42hAntibiotics for Pediatric Pneumonia: Might Less Be Enough? – Annals of Emergency Medicine
Conteúdos relacionados:
Treatment of UTIs in Infants <2 Months: A Living Systematic Review – Hospital Pediatrics
Estudo randomizado | Comparação de antibioticoterapia por 8 vs. 15 dias para pneumonia por Pseudomonas aeruginosa associada a ventilador mecânico em adultos.
17 Mai, 2022 | 12:07hComparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial – Intensive Care Medicine (artigo gratuito aqui)
Comentário no Twitter
🧫 8 vs 15 days ABT for Pseudomonas aeruginosa VAP in adults, iDIAPASON RCT: no differences in composite or separate outcomes (90-day mortality/VAP recurrence) between short & long duration treatment.
📢 @yourICM ground-breaking release #LIVES40 #FOAMcc
🖇 https://t.co/LfoUWxCkkl pic.twitter.com/XaWkQ5R6wT— Intensive Care Medicine (@yourICM) May 13, 2022
Diagnóstico molecular na pneumonia grave: um novo começo ou uma falsa promessa?
17 Mai, 2022 | 11:46hMolecular diagnostics in severe pneumonia: a new dawn or false promise? – Intensive Care Medicine
Comentário no Twitter
Pneumonia? no gold standard diagnosis available, likely resulting in overtreatment. Molecular diagnostics more widely available even if interpretation/use complex, requiring to take into account data/characteristics when making decisions based on these.
📎 https://t.co/mae0vxBfkF pic.twitter.com/bbkxGLEumN— Intensive Care Medicine (@yourICM) May 14, 2022
Infecções esqueléticas: patogênese microbiológica, imunidade e tratamento clínico.
16 Mai, 2022 | 16:29hSkeletal infections: microbial pathogenesis, immunity and clinical management – Nature Reviews Microbiology (se o acesso a este link for pago, tente este)
Revisão liderada por farmacêuticos pode melhorar as prescrições de antibióticos na alta hospitalar.
16 Mai, 2022 | 16:25hComentário: Pharmacist-led review tied to better antimicrobial prescribing at discharge – CIDRAP
Estudo original: Pharmacist-Driven Transitions of Care Practice Model for Prescribing Oral Antimicrobials at Hospital Discharge – JAMA Network Open
Revisão sistemática | Antibioticoprofilaxia na prevenção de endocardite bacteriana após procedimentos dentários.
13 Mai, 2022 | 12:56h
Comentário no Twitter
Have a look at the evidence on antibiotics for preventing bacterial endocarditis in people undergoing dental treatment. Summary here: https://t.co/7uxnkbgt8t. Full review here: https://t.co/3Au3EsHZIU pic.twitter.com/RLsF3fHiZa
— Cochrane Oral Health (@CochraneOHG) May 11, 2022
Uso de novas estratégias de desenvolvimento de diretrizes para tratamento de osteomielite piogênica em adultos: diretriz de consenso do grupo WikiGuidelines.
12 Mai, 2022 | 15:23hComentário: A new approach to medical guidelines, taking inspiration from Wikipedia – University of Michigan
Comentário no Twitter
This consensus statement & systematic review uses a WikiGuidelines methodology for clinical guideline development (precluding recommendations based on low-quality data/opinion), addressing 7 questions regarding osteomyelitis management. @BradSpellberg https://t.co/MVjkzC5rdf
— JAMA Network Open (@JAMANetworkOpen) May 10, 2022
Estudo randomizado | Doxiciclina vs. azitromicina no tratamento da infecção anorretal por Chlamydia trachomatis em mulheres.
12 Mai, 2022 | 15:17hDoxycycline versus azithromycin for the treatment of anorectal Chlamydia trachomatis infection in women concurrent with vaginal infection (CHLAZIDOXY study): a multicentre, open-label, randomised, controlled, superiority trial – The Lancet Infectious Diseases (link para o resumo – $ para o texto completo)
Comentário: Doxycycline Bests Azithromycin for Anogenital Chlamydia in Women — Open-label randomized trial set out to duplicate results from prior studies in men – MedPage Today (necessário cadastro gratuito)
Conteúdos relacionados:
Estudo de coorte | Meningite bacteriana adquirida na comunidade em pacientes de 80 anos de idade ou mais.
12 Mai, 2022 | 14:58hDoença do legionário: atualização em diagnóstico e tratamento.
12 Mai, 2022 | 14:42hLegionnaires’ Disease: Update on Diagnosis and Treatment – Infectious Diseases and Therapy
Comentário no Twitter
Legionellosis is becoming increasingly important as a public health problem throughout the world; although it is an underreported disease!
Fantastic 🆕💥Review Article @InfectDis_Ther
Legionnaires’ Disease: Update on Diagnosis and Treatment #IDTwitter https://t.co/OvmZZZRz6n pic.twitter.com/vCu7MZdnKs— Antibiotic Steward Bassam Ghanem🆔🔥 (@ABsteward) May 7, 2022
Sob licença de http://creativecommons.org/licenses/by-nc/4.0/


